ROYAL BANK OF CANADA - EYEGATE PHARMACEUTICALS INC ownership

EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EYEGATE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,000
-33.3%
1,6900.0%0.00%
Q2 2021$6,000
-25.0%
1,6900.0%0.00%
Q1 2021$8,0000.0%1,6900.0%0.00%
Q4 2020$8,000
+14.3%
1,6900.0%0.00%
Q3 2020$7,000
-12.5%
1,6900.0%0.00%
Q2 2020$8,000
-11.1%
1,6900.0%0.00%
Q1 2020$9,000
-47.1%
1,6900.0%0.00%
Q4 2019$17,000
+466.7%
1,690
+105.1%
0.00%
Q3 2019$3,0008240.00%
Other shareholders
EYEGATE PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sassicaia Capital Advisers LLC 25,000$56,0000.16%
Tuttle Capital Management, LLC 18,174$41,0000.05%
XTX Topco Ltd 13,867$31,0000.01%
Sterling Financial Planning, Inc. 1,171$3,0000.00%
Tower Research Capital LLC (TRC) 13,832$31,0000.00%
Newbridge Financial Services Group, Inc. 1,000$2,0000.00%
JANE STREET GROUP, LLC 34,742$78,0000.00%
UBS Group AG 399$1,0000.00%
OSAIC HOLDINGS, INC. 1,468$3,0000.00%
US BANCORP \DE\ 2,710$6,0000.00%
View complete list of EYEGATE PHARMACEUTICALS INC shareholders